# Allogeneic HSCT in MDS Patients Based on Risk According to R-IPSS

> **NCT04801563** · NA · UNKNOWN · sponsor: **University Of Perugia** · enrollment: 80 (estimated)

## Conditions studied

- MDS and Allogeneic Stem Cell Transplantation

## Interventions

- **OTHER:** MDS and AlloHSCT

## Key facts

- **NCT ID:** NCT04801563
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-20
- **Primary completion:** 2025-09-19
- **Final completion:** 2025-09-19
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801563, "Allogeneic HSCT in MDS Patients Based on Risk According to R-IPSS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04801563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*